Correlation Between Rekah Pharmaceutical and Bezeq Israeli

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Bezeq Israeli at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Bezeq Israeli into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Bezeq Israeli Telecommunication, you can compare the effects of market volatilities on Rekah Pharmaceutical and Bezeq Israeli and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Bezeq Israeli. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Bezeq Israeli.

Diversification Opportunities for Rekah Pharmaceutical and Bezeq Israeli

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Rekah and Bezeq is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Bezeq Israeli Telecommunicatio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bezeq Israeli Teleco and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Bezeq Israeli. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bezeq Israeli Teleco has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Bezeq Israeli go up and down completely randomly.

Pair Corralation between Rekah Pharmaceutical and Bezeq Israeli

Assuming the 90 days trading horizon Rekah Pharmaceutical Industry is expected to generate 2.03 times more return on investment than Bezeq Israeli. However, Rekah Pharmaceutical is 2.03 times more volatile than Bezeq Israeli Telecommunication. It trades about 0.01 of its potential returns per unit of risk. Bezeq Israeli Telecommunication is currently generating about 0.01 per unit of risk. If you would invest  159,400  in Rekah Pharmaceutical Industry on August 29, 2024 and sell it today you would lose (17,200) from holding Rekah Pharmaceutical Industry or give up 10.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rekah Pharmaceutical Industry  vs.  Bezeq Israeli Telecommunicatio

 Performance 
       Timeline  
Rekah Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rekah Pharmaceutical Industry has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Rekah Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Bezeq Israeli Teleco 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Bezeq Israeli Telecommunication are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bezeq Israeli sustained solid returns over the last few months and may actually be approaching a breakup point.

Rekah Pharmaceutical and Bezeq Israeli Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rekah Pharmaceutical and Bezeq Israeli

The main advantage of trading using opposite Rekah Pharmaceutical and Bezeq Israeli positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Bezeq Israeli can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bezeq Israeli will offset losses from the drop in Bezeq Israeli's long position.
The idea behind Rekah Pharmaceutical Industry and Bezeq Israeli Telecommunication pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine